Greek Researchers Develop Promising Drug for Alzheimers

Researchers in Greece have identified a new drug candidate, designated RSQ-020, that has demonstrated the ability to restore learning and memory functions in preclinical animal models of Alzheimer’s disease. The development represents a potential shift in therapeutic strategy for addressing the condition.

The molecule functions by targeting the Tau protein, which is known to misfold and form aggregates associated with the progression of Alzheimer’s. While the findings are limited to preclinical studies, the research offers a new approach to treating the underlying mechanisms of the disease.